The annual Enforcement, Litigation, and Compliance Conference brings together industry, regulators, attorneys, litigators, academics, and consultants to discuss trends and issues in enforcement and compliance, the latest developments in both civil and criminal litigation, and recent cases and settlements. This conference offers an opportunity to hear from and interact with top officials from FDA, DOJ, FTC, and other government agencies.
Attendees will:
- Explore the latest trends behind enforcement actions in food, drugs, biologics, medical devices, and tobacco
- Gain practical tips and best practices for responding to enforcement action by FDA or other government agencies
- Learn how to comply with new and upcoming FDA rules and regulations
- Hear about top issues, priorities, and goals for 2020 directly from ORA and FDA’s Center Compliance Directors
Keynote Address (December 11): David Morrell, Deputy Assistant Attorney General, Consumer Protection Branch, Civil Division, Department of Justice
Keynote Address (December 12): Stacy Cline Amin, Chief Counsel, FDA
Seventh Annual Eric M. Blumberg Memorial Lecture: Richard M. Cooper, Senior Counsel at Williams & Connolly LLP
Call For Proposals
FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this summer. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in December.
Sponsors
Sponsorship opportunities are available. Please let us know if you would like more information.
Planning Committee
Committee Members
Kalah Auchincloss, Greenleaf Health, Inc.
Erica Battaglia, Abbott Laboratories
Hannah Bornstein, Nixon Peabody LLP
Adrienne Franco Busby, Faegre Baker Daniels LLP
Patrick Gallagher, Duane Morris LLP
Jonathan Gil, Pfizer, Inc.
Sonali P. Gunawardhana, Shook, Hardy & Bacon LLP
Daniel G. Jarcho, Alston & Bird LLP
Howard R. Sklamberg, Akin Gump Strauss Hauer & Feld LLP
Michael A. Swit, Law Offices of Michael A. Swit
Jessica Zeller, FDA – ORA
Committee Chair
Anne K. Walsh, Hyman, Phelps & McNamara, PC